148 related articles for article (PubMed ID: 18262771)
1. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.
Saddichha S; Manjunatha N; Ameen S; Akhtar S
Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771
[TBL] [Abstract][Full Text] [Related]
2. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
Saddichha S; Manjunatha N; Ameen S; Akhtar S
J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
[TBL] [Abstract][Full Text] [Related]
4. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
[TBL] [Abstract][Full Text] [Related]
5. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
Meyer JM; Davis VG; Goff DC; McEvoy JP; Nasrallah HA; Davis SM; Rosenheck RA; Daumit GL; Hsiao J; Swartz MS; Stroup TS; Lieberman JA
Schizophr Res; 2008 Apr; 101(1-3):273-86. PubMed ID: 18258416
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
[TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
[TBL] [Abstract][Full Text] [Related]
12. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
[TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
[TBL] [Abstract][Full Text] [Related]
15. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.
Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
Schizophr Res; 2007 Feb; 90(1-3):162-73. PubMed ID: 17123783
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia.
Saddichha S; Manjunatha N; Ameen S; Akhtar S
Acta Psychiatr Scand; 2008 May; 117(5):342-7. PubMed ID: 18307585
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of electroacupuncture on metabolic syndrome due to olanzapine and risperidone: Study protocol for a randomized controlled pilot trial.
Ning Y; Jia H; Chen P; Zhu H; Yin D
Medicine (Baltimore); 2019 Sep; 98(38):e17237. PubMed ID: 31567988
[TBL] [Abstract][Full Text] [Related]
20. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.
Lee NY; Kim SH; Cho B; Lee YJ; Chang JS; Kang UG; Kim YS; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1243-9. PubMed ID: 20599461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
